InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Keson-Brookes Maiken. Officer active across 2 companies, notably Rubius Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €25k. History available since 14 December 2023. The latest transaction was filed on 22 July 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Keson-Brookes Maiken is a declarant linked to Mural Oncology plc, where the listed role is Chief Legal Officer, and to Rubius Therapeutics, Inc., where the listed role is CLO & Corp. Secretary. There are 9 filings in total. Across the 9 most recent sampled filings, all transactions are sales, for a total of EUR 24796, with a date range from 2022-02-01 to 2025-12-05.